MeSH term
Frequency | Condition_Probility | Autoradiography | 4 | 0.0 |
Comparative Study | 17 | 0.0 |
Humans | 142 | 0.0 |
Lymphatic Metastasis | 3 | 0.0 |
Receptors, Bombesin/*metabolism | 5 | 38.0 |
Tissue Distribution | 2 | 0.0 |
Adolescent | 8 | 0.0 |
Adult | 31 | 0.0 |
Aged | 12 | 0.0 |
Female | 35 | 0.0 |
Male | 46 | 0.0 |
Middle Aged | 22 | 0.0 |
Animals | 55 | 0.0 |
Blotting, Western | 6 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Cell Line | 15 | 0.0 |
Endoplasmic Reticulum/*metabolism | 3 | 2.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Hamsters | 4 | 0.0 |
*Heat-Shock Proteins | 4 | 6.0 |
Mice | 26 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 13 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
Transfection | 9 | 0.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Amino Acid Sequence | 24 | 0.0 |
Gastrin-Releasing Peptide/metabolism | 6 | 75.0 |
Genetic Vectors | 2 | 0.0 |
Ligands | 4 | 0.0 |
Molecular Sequence Data | 30 | 0.0 |
Peptides/*genetics/metabolism | 2 | 7.0 |
Kinetics | 9 | 0.0 |
Neuropeptides/*metabolism | 3 | 3.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
Substrate Specificity | 4 | 0.0 |
Vasoactive Intestinal Peptide/metabolism | 5 | 7.0 |
Cell Division/drug effects | 8 | 0.0 |
Gastrin-Releasing Peptide/*pharmacology | 2 | 100.0 |
Peptide Fragments/*pharmacology | 2 | 1.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Mice, Nude | 5 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Receptors, Bombesin/biosynthesis/genetics | 2 | 66.0 |
Flow Cytometry | 3 | 0.0 |
Binding Sites | 4 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Fibroblasts | 2 | 0.0 |
Tumor Cells, Cultured | 22 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Bombesin/*analogs & derivatives/*pharmacology | 2 | 100.0 |
Cross-Over Studies | 2 | 0.0 |
Dose-Response Relationship, Drug | 8 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Eating/physiology | 2 | 3.0 |
Gastric Acid/*secretion | 5 | 8.0 |
Glucose/*physiology | 2 | 18.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Molecular Chaperones/*metabolism | 2 | 3.0 |
Age Factors | 4 | 0.0 |
Molecular Chaperones/*biosynthesis | 3 | 50.0 |
Time Factors | 4 | 0.0 |
3T3 Cells | 3 | 0.0 |
Base Sequence | 15 | 0.0 |
Hela Cells | 2 | 0.0 |
*Response Elements | 2 | 3.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Prostatic Neoplasms/*pathology | 2 | 1.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Rats | 19 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
*Brain Chemistry | 2 | 1.0 |
Reference Values | 4 | 0.0 |
Receptors, Bombesin/*antagonists & inhibitors | 2 | 40.0 |
Phosphorylation | 4 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Gene Expression | 6 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 4 | 0.0 |
Phenotype | 3 | 0.0 |
Immunoenzyme Techniques | 4 | 0.0 |
CHO Cells | 2 | 0.0 |
Colonic Neoplasms/*metabolism | 2 | 2.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Autoantigens/immunology | 2 | 1.0 |
Cell Division | 2 | 0.0 |
Mice, Inbred BALB C | 8 | 0.0 |
Neoplasm Transplantation | 3 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Gastrin-Releasing Peptide/pharmacology | 2 | 33.0 |
Thymidine/metabolism | 3 | 0.0 |
Receptors, Bombesin/metabolism | 2 | 28.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Hyperplasia | 2 | 0.0 |
Iodine Radioisotopes | 4 | 1.0 |
Radioligand Assay | 2 | 0.0 |
Immunohistochemistry | 21 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Calcium/metabolism | 7 | 0.0 |
Membrane Proteins/*biosynthesis | 2 | 3.0 |
Calcitonin Gene-Related Peptide/pharmacology | 2 | 6.0 |
Neuropeptides/*pharmacology | 2 | 3.0 |
Substance P/pharmacology | 2 | 6.0 |
English Abstract | 6 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Stimulation, Chemical | 3 | 0.0 |
Peptides/metabolism/*pharmacology | 2 | 8.0 |
Fetus | 4 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Sheep | 4 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Neurokinin B/analogs & derivatives/metabolism | 2 | 100.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Receptors, Bombesin/*genetics | 2 | 28.0 |
Bombesin/metabolism | 4 | 57.0 |
Radioimmunoassay | 13 | 0.0 |
Substance P/metabolism | 2 | 3.0 |
Gastrin-Releasing Peptide | 62 | 70.0 |
Peptides/*immunology | 2 | 2.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Infant | 6 | 0.0 |
Infant, Newborn | 8 | 0.0 |
Peptides/analysis | 3 | 3.0 |
Substance P/analysis | 2 | 2.0 |
Vasoactive Intestinal Peptide/analysis | 4 | 4.0 |
In Vitro | 5 | 0.0 |
Peptides/*pharmacology | 9 | 4.0 |
Gastrins/*metabolism | 2 | 12.0 |
Peptide Biosynthesis | 5 | 10.0 |
Tumor Markers, Biological | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Peptides/pharmacology | 5 | 2.0 |
Structure-Activity Relationship | 4 | 0.0 |
DNA/genetics | 2 | 0.0 |
Gastrointestinal Hormones/pharmacology | 4 | 44.0 |
Protein Precursors/*genetics | 2 | 1.0 |
Eating | 2 | 1.0 |
DNA Primers | 4 | 0.0 |
Epithelial Cells | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Inositol Phosphates/metabolism | 2 | 1.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 18 | 3 | 2.0 |
Neuropeptides/genetics | 2 | 9.0 |
Peptides/genetics | 3 | 3.0 |
Chromatography, Gel | 4 | 0.0 |
Gastrins/secretion | 4 | 30.0 |
Helicobacter pylori | 2 | 5.0 |
Bombesin/analogs & derivatives/metabolism | 2 | 100.0 |
Bombesin/pharmacology | 2 | 13.0 |
Cell Line, Transformed | 2 | 0.0 |
Cholecystokinin/antagonists & inhibitors/*physiology | 2 | 20.0 |
Proglumide/analogs & derivatives/pharmacology | 3 | 12.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Organ Culture Techniques | 3 | 0.0 |
Peptides/metabolism | 3 | 1.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Neuropeptides/*analysis | 3 | 3.0 |
Calcium/diagnostic use | 2 | 33.0 |
Gastrointestinal Hormones/*secretion | 2 | 5.0 |
Gastrins/blood | 3 | 4.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Histocytochemistry | 3 | 0.0 |
Chromatography, High Pressure Liquid | 5 | 0.0 |
Gastrins/pharmacology | 2 | 16.0 |
Gastric Acid/secretion | 3 | 6.0 |
Gastrointestinal Hormones/*pharmacology | 2 | 7.0 |
Receptors, Bombesin | 5 | 62.0 |
Receptors, Neurotransmitter/*metabolism | 2 | 7.0 |
Species Specificity | 2 | 0.0 |
Swine | 2 | 0.0 |
Vasoactive Intestinal Peptide/pharmacology | 2 | 2.0 |
Rats, Inbred Strains | 5 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Carcinoma, Small Cell/*metabolism | 2 | 8.0 |
Lung Neoplasms/*metabolism | 3 | 3.0 |
Carcinoma, Small Cell/metabolism | 2 | 25.0 |
Gastrointestinal Hormones/*analysis | 2 | 7.0 |
Peptides/*analysis | 6 | 8.0 |
Peptides/*analysis/blood | 2 | 100.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Peptides/*genetics | 5 | 5.0 |
Neurons/*analysis | 2 | 18.0 |
Carcinoma, Small Cell/*analysis | 2 | 66.0 |
Lung Neoplasms/*analysis | 3 | 30.0 |
Bombesin/analysis | 2 | 11.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Corticotropin/*secretion | 2 | 4.0 |
Dogs | 2 | 0.0 |
Calcitonin Gene-Related Peptide | 3 | 12.0 |
Fetus/*analysis | 2 | 28.0 |
DNA Restriction Enzymes | 2 | 0.0 |
Nerve Fibers/*analysis | 2 | 20.0 |
